Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New HIV guidance released

  • Comment
Experts in HIV have updated their guidelines for treatment of the infection.

The International AIDS Society-USA guidelines support initiating antiretroviral therapy before CD4 cell count declines to less than 350/ μL.

Rapid decline in CD4 cell count, high plasma HIV-1 RNA levels, risk factors for cardiovascular disease and the presence of other diseases such as hepatitis B or C should be considered when deciding when to initiate therapy.

The initial drug regimen should be tailored to the individual, particular in the presence of other illnesses, authors write.

Levels of HIV-1 RNA in blood plasma should also be monitored frequently, the guidelines say.

Journal of the American Medical Association (2008) 300:555-570

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.